Green Fresh Biotechnology Co Ltd

Green Fresh Biotechnology Co Ltd maintains a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.68, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of CNY 16.07 million is available for reinvestment or shareholder returns, though operating cash flow of CNY 6.97 million is relatively low compared to capital expenditures of CNY -26.1 million. Profitability metrics show a return on equity of 0.79% and a return on assets of 0.4%, both below the industry median for Food Processing. Gross profit of CNY 167.23 million represents 18.5% of revenue, but operating income of CNY 34.57 million and net income of CNY 6.59 million indicate thin margins. These figures suggest the company is under pressure to improve operational efficiency and pricing power. The company's revenue is distributed across five segments, with no single segment accounting for more than 50% of total revenue. The largest segment, Agar-agar, is followed by Carrageenan and Blended Products. Geographic exposure is not disclosed in the input data, but the company's operations are likely concentrated in China given its listing and production base. Outlook for the current fiscal year shows a modest revenue growth trajectory, though specific numeric deltas are not provided in the input data. Capital expenditures are negative, indicating asset disposals or reduced investment in production capacity. The company's ability to sustain growth will depend on its capacity to expand into new markets and diversify its product portfolio. Risk factors include a negative net cash position after subtracting total debt, which could limit financial flexibility. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. However, the company's reliance on thin margins and moderate liquidity could expose it to volatility in raw material costs and demand fluctuations. Recent events include the 2023 annual report filing, which disclosed the financial snapshot and risk assessment. No recent earnings call transcripts or material regulatory filings are included in the input data, limiting visibility into management's strategic direction or near-term plans.